Product Information
Name:TG4-155
Brand:Biosynth
Description:TG4-155 is a low potency antiplatelet drug that is a selective antagonist for the prostacyclin receptor. It was initially developed to treat cancer, as it inhibits tumor growth and induces apoptosis in cancer cells. TG4-155 has been shown to be effective in vivo models of breast, prostate, and colon cancers. TG4-155 was also shown to reduce platelet aggregation in primary cells from ovaries and other tissues.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:394.46 g/mol
Formula:C23H26N2O4
Purity:Min. 95%
Technical inquiry about: TG4-155
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.